Missed CHI's Immunogenicity & Bioassay Summit This Year?
Access content from this year's event On-Demand at your convenience - from anywhere, at any time.
Join us at the #1 Immunogenicity & Bioassay Event in the U.S. Bringing Together Industry, Academia & Regulatory Authorities
RESOLVE the CHALLENGES of immunogenicity testing and risk assessment during preclinical and clinical development, bioassay design & analysis, and how to manipulate the immune system for therapeutic advantage by attending CHI's 15th Annual Immunogenicity & Bioassay Summit on October 2-5, 2023, at The Watergate Hotel in Washington, D.C. The summit features 5 FDA presentations, 50+ additional speakers, 3 conferences, symposium, workshop, short courses, and interactive breakout discussions. Join 200+ attendees from 15 countries including the FDA. Track-hopping is allowed for sessions happening at the same time. The sessions will livestream on Eastern Time for those unable to travel. We hope you will join us.
5 FDA Speakers Will Share Crucial Updates
Kristina Howard, PhDCDER, FDA
Ronit Mazor, PhDCBER, FDA
Zuben Sauna, PhDCBER, FDA
Anurag Sharma, PhDCBER, FDA
Yow-Ming Wang, PhDCDER, FDA
Hear From Industry and Academic Experts
Ethan Shevach, MDNIAID, NIH
Amy Rosenberg, MDEpivax
Alexander Kozhich, PhDBristol Myers Squibb
Jianfang HuPfizer
Jason PennucciModerna
Alessandro Sette, PhDLa Jolla Institute for Allergy & Immunology
Soumi Gupta, PhDBioMarin Pharmaceutical
Linlin Luo, PhDMerck
Thank You to Our 2023 Sponsors
Corporate Sponsors:
View All Sponsors
Connect with a Focused Audience: Become a Sponsor or Exhibitor
Whether you’re targeting the entire conference community of life sciences, pharmaceutical, clinical, healthcare, and IT professionals, a topic-specific community, a specific individual, or high-level decision makers, we offer a variety of methods to access our esteemed delegates. Explore our sponsor or exhibitor packages which offer a wide range of platforms to launch products, gain exposure, collect feedback, network and generate new leads.
